Circumventing Furin Enhances Factor VIII Biological Activity and Ameliorates Bleeding Phenotypes in Hemophilia Models

JCI insight - United States
doi 10.1172/jci.insight.89371
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Postpartum Acquired Hemophilia Factor VIII �nhibitors and Response to Therapy

Turkish Journal of Haematology
Hematology
2012English

Features of Factor VIII Activity Measurement in Arg531His Mutant Detected in Patients With Mild Hemophilia A

Japanese Journal of Thrombosis and Hemostasis
2008English

Improving the Performance of Factor VIII Inhibitor Tests in Hemophilia A

Thrombosis Research
Hematology
2015English

Survival of 125iodine-Labeled Factor VIII in Normals and Patients With Classic Hemophilia. Observations on the Heterogeneity of Human Factor VIII.

Journal of Clinical Investigation
Medicine
1978English

Factor VIII Associated With Lipidic Nanoparticles Retains Efficacy in the Presence of Anti-Factor VIII Antibodies in Hemophilia a Mice

Biopharmaceutics and Drug Disposition
MedicinePharmacologyPharmaceutical Science
2016English

Prevalence of Inhibitors to Factor VIII After 25 Exposures to Factor VIII Concentrates and/or Blood Products in Persons With Hemophilia A

Journal of Medical Science And Clinical Research
2017English

AMulticenter Clinical Study of Recombinant Factor VIII (BL-160) in Hemophilia a Patients

Japanese Journal of Thrombosis and Hemostasis
1993English

Clotting Factor Concentrates Given to Prevent Bleeding and Bleeding-Related Complications in People With Hemophilia a or B

2006English

Clot Stability as a Determinant of Effective Factor VIII Replacement in Hemophilia A

Research and Practice in Thrombosis and Haemostasis
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy